Estimating the magnitude and direction of bias in tuberculosis drug resistance surveys conducted only in the public sector: A simulation study

BMC Public Health

Volumn 10, Issue , 2010, Pages

  Cohen, Ted ^a,b   Hedt, Bethany L ^b   Pagano, Marcello ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; EPIDEMIOLOGY; FEMALE; HUMAN; INDIA; INFORMATION PROCESSING; LUNG TUBERCULOSIS; MALE; METHODOLOGY; ORGANIZATION AND MANAGEMENT; THEORETICAL MODEL;

ADULT; BIAS (EPIDEMIOLOGY); DATA COLLECTION; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INDIA; MALE; MODELS, THEORETICAL; PUBLIC SECTOR; TUBERCULOSIS, PULMONARY;

EID: 77953680717     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-10-355     Document Type: Article

References (23)

1. Anti-tuberculosis drug resistance in the world: report 4 Geneva: World Health Organization 2008
2. Initial drug resistance and tuberculosis treatment outcomes: systematic review and meta-analysis. W Lew M Pai O Oxlade D Martin D Menzies, Ann Intern Med 2008 149 123 34 18626051
3. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. MA Espinal SJ Kim PG Suarez KM Kam AG Khomenko GB Migliori J Baéz A Kochi C Dye MC Raviglione, JAMA 2000 283 2537 45 10.1001/jama.283.19.2537 10815117
4. Worldwide emergence of extensively drug-resistant tuberculosis. NS Shah A Wright GH Bai L Barrera F Boulahbal N Martín-Casabona F Drobniewski C Gilpin M Havelkov R Lepe R Lumb B Metchock F Portaels MF Rodrigues S Rüsch-Gerdes A Van Deun V Vincent K Laserson C Wells JP Cegielski, EID 2007 13 380 7 10.3201/eid1303.061400
5. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. NR Gandhi A Moll AW Sturm R Pawinski T Govender U Lalloo K Zeller J Andrews G Friedland, Lancet 2006 368 1575 80 10.1016/S0140-6736(06)69573-1 17084757
6. XDR-TB: entering the post-antibiotic era? M Raviglione, Int J Tuberc Lung Dis 2006 10 1185 7 17131774
7. Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. A Wright M Zignol A Van Deun D Falzon SR Gerdes K Feldman S Hoffner F Drobniewski L Barrera D van Soolingen F Boulabhal CN Paramasivan KM Kam S Mitarai P Nunn M Raviglione Global Project on Anti-Tuberculosis Drug Resistance Surveillance, Lancet 2009 e-published Apr 15
8. Guidelines for surveillance of drug resistance in tuberculosis Geneva: World Health Organization second 2003
9. Tuberculosis patients and practitioners in private clinics in India. M Uplekar S Juvekar S Morankar S Rangan P Nunn, Int J Tuberc Lung Dis 1998 2 324 9 9559404
10. Private practitioners and public health: weak links in tuberculosis control. M Uplekar V Pathania M Raviglione, Lancet 2001 358 912 6 10.1016/S0140-6736(01)06076-7 11567729
11. TB patients and Private For-Profit Health Care Providers in India Geneva: World Health Organization 1997
12. Global tuberculosis control: surveillance, planning, financing Geneva: World Health Organization 2008
13. Health care seeking among individuals with cough and tuberculosis: a population-based study from rural India. G Fochsen K Deshpande V Diwan A Mishra V Diwan A Thorson, Int J Tuberc Lung Dis 2006 10 995 1000 16964790
14. Health seeking and knowledge about tuberculosis among persons with pulmonary symptoms and tuberculosis cases in Bangalore slums. P Suganthi VK Chadha J Ahmed G Umadevi P Kumar R Srivastava V Magesh J Gupta MA Sharda, Int J Tuberc Lung Dis 2008 12 1268 73 18926036
15. Cost and cost-effectiveness of PPM-DOTS for tuberculosis control: evidence from India. K Floyd VK Arora KJ Murthy K Lonnroth N Singla Y Akbar M Zignol M Uplekar, Bull World Health Organ 2006 84 437 45 10.2471/BLT.05.024109 16799727
16. Improving tuberculosis control through public-private collaboration in India: literature review. PK Dewan SS Lal K Lonnroth F Wares M Uplekar S Sahu R Granich LS Chauhan, BMJ 2006 332 574 8 10.1136/bmj.38738.473252.7C 16467347
17. Diagnostic evaluation of pulmonary tuberculosis: what do doctors of modern medicine do in India? R Prasad R Nautiyal P Mukherji A Jain K Singh R Ahuja, Int J Tuberc Lung Dis 2003 7 52 7 12701835
18. Compliance with DOTS diagnosis and treatment recommendations by private practitioners in Kerala, India. F Greaves H Ouyang M Pefole S MacCarthy R Cash, Int J Tuberc Lung Dis 2007 11 110 2 17217139
19. Source of retreatment cases under the revised national TB control programme in Rajasthan, India, 2003. R Sisodia D Wares S Sahu L Chauhan M Zignol, Int J Tuberc Lung Dis 2006 10 1373 9 17167955
20. Health Indicators: Eliminating bias from convenience sampling indicators. BL Hedt M Pagano, Statistics in Medicine
21. Notes on the Theory of Association of Attributes in Statistics. G Yule, Biometrika 1903 2 121 134 10.1093/biomet/2.2.121
22. The Interpretation of Interaction in Contingency Tables. E Simpson, Journal of the Royal Statistical Society. Series B 1951 13 238 241
23. Guidelines for the surveillance of drug resistance in tuberculosis Geneva: World Health Organization fourth 2009